Source: https://xepc.eu/node/t950272
Timestamp: 2020-02-21 15:20:11
Document Index: 623018431

Matched Legal Cases: ['Art 24', 'Art 58', 'Art 59', 'Art 78', 'Art 133', 'Art 134', 'Art 9', 'Art 2']

T 0272/95 (Admissibility of joint opposition or joint appeal) of 15.4.1999 | XEPC: EPC and PCT resource
T 0272/95 (Admissibility of joint opposition or joint appeal) of 15.4.1999
ECLI:EP:BA:1999:T027295.19990415
83307553.4
C12N 15/16
Decision text in EN (PDF, 42.366K)
Molecular cloning and characterization of a further gene sequence coding for human relaxin
Aglietta, Amendola et al., Fraktion der GrÃ¼nen im EP
The following questions are referred to the Enlarged Board of Appeal: 1. Is an opposition admissible which otherwise meets the requirements of Article 99 EPC and Rule 55 EPC if it is filed jointly by two or more persons and only one opposition fee is paid?
2. If the answer to question 1 is in the affirmative and a common representative was named under Rule 100(1) EPC in the notice of opposition, is an appeal valid even if it is not filed by this person?
3. If the answers to questions 1 and 2 are in the affirmative, which other requirements, if any, have to be met by a joint opposition or a joint appeal in order to safeguard the rights of the patent proprietor?
European Patent Convention 1973 Art 24
European Patent Convention 1973 Art 58
European Patent Convention 1973 Art 59
European Patent Convention 1973 Art 78
European Patent Convention 1973 Art 133
European Patent Convention 1973 Art 134
European Patent Convention 1973 R 17
European Patent Convention 1973 R 26
European Patent Convention 1973 R 60
European Patent Convention 1973 R 63
European Patent Convention 1973 R 66
European Patent Convention 1973 R 78
European Patent Convention 1973 R 90
European Patent Convention 1973 R 92
European Patent Convention 1973 R 100
European Patent Convention 1973 R 101
European Patent Convention 1973 R 102
European Patent Convention 1973 R 106
Patent Cooperation Treaty Art 9
Patent Cooperation Treaty R 2
Patent Cooperation Treaty R 90
Rules relating to fees Art 2
Joint oppositions - fees due - common representative - joint appeals - admissibility - important point of law - referral to the Enlarged Board of Appeal
J 0035/92
T 1018/98
T 0543/99
T 0080/05
T 0666/05
XR.2 PCT Interpretation of Certain Words
XR.90 PCT Agents and Common Representatives
XCLR I B 2 of "ordre public" or morality
XG 0003/97 (Opposition on behalf of a third party) of 21.1.1999
XG 0004/97 (Opposition on behalf of a third party/GENENTECH) of 21.1.1999
XG 0003/99 (Admissibility of joint opposition or joint appeal/HOWARD FLOREY) of 18.2.2002
XJ 0003/87 (Membranes) of 2.12.1987
XJ 0035/92 () of 17.3.1994
XT 0355/86 () of 14.4.1987
XT 0371/92 (Appeal not filed) of 2.12.1993
XT 0543/99 () of 24.10.2000
XT 0315/03 (Transgenic animals/HARVARD) of 6.7.2004
XT 1374/04 (Stem cells/WARF) of 7.4.2006
XT 0080/05 (Method of diagnosis/UNIVERSITY OF UTAH) of 19.11.2008
XT 0666/05 (Mutation/UNIVERSITY OF UTAH) of 13.11.2008
XT 1213/05 (Breast and ovarian cancer/UNIVERSITY OF UTAH) of 27.9.2007
T 0236/95 () of 16.7.1996
T 0240/95 (Conversion of heavy feedstock/SHELL) of 6.7.1999
T 0241/95 (Serotonin receptor/ELI LILLY) of 14.6.2000
T 0252/95 (Schokoladenmassentemperierung / SOLLICH) of 21.8.1998
T 0253/95 () of 17.12.1997
T 0277/95 (Production of erythropoietin/GENETICS INSTITUTE) of 16.4.1999
T 0280/95 () of 23.10.1996
T 0281/95 () of 24.9.1996
T 0301/95 (Straw man) of 27.6.1997